SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000812796-09-000018
Filing Date
2009-03-30
Accepted
2009-03-30 16:50:16
Documents
9
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 DOR 10 K FOR 2008 dor10k2008.htm 10-K 1414108
2 DR. SCHABER EMPLOYMENT AGREEMENT schaberempagree.htm EX-10.30 58884
3 MR. MYRIANTHOPOULOS EMPLOYMENT AGREEMENT myrianthopoulosempagree.htm EX-10.31 57731
4 MR. CLAVIJO EMPLOYEE AGREEMENT clavijoempagree.htm EX-10.32 59160
5 SUBSIDIARIES subsidiaries.htm EX-21.1 5281
6 CEO CERTIFICATION ceocert.htm EX-31.1 12623
7 CFO CERTIFICATION cfocert.htm EX-31.2 12337
8 CEO SOX 906 CERTIFICATION ceosox906.htm EX-32.1 7385
9 CFO SOX 906 CERTIFICATION cfosox906.htm EX-32.2 6819
  Complete submission text file 0000812796-09-000018.txt   1635953
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-452-0001
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16929 | Film No.: 09714714
SIC: 2834 Pharmaceutical Preparations